Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
Q.7 (Alpha)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.460NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.262NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EG.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBUNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.351.5 (Beta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FZ.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.9.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBC.1.6.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.4.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FQ.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JB.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.17NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.3.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FZ.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
DV.7.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.30.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.5.68NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CD.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.122.3 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.43.6 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBF.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.27NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.43.9 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XUNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.3 (Omicron)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.16.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.372NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.128NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.33NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.405NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.296NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.412NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AC.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
C.27NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.421NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.364NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.82NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.61NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.70NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.43NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.559NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.14NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.406NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.69NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
A.26NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
ER.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used